{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:48:18Z","timestamp":1787676498451,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["(V104C-151, V105C-067)"],"award-info":[{"award-number":["(V104C-151, V105C-067)"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Taipei City Hospital","award":["(104 No.35, M-1A00-B-B17-35)"],"award-info":[{"award-number":["(104 No.35, M-1A00-B-B17-35)"]}]},{"DOI":"10.13039\/501100009096","name":"Taiwan Clinical Oncology Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009096","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chong Hin Loon Memorial Cancer and the Biotherapy Research Center of National Yang-Ming University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-016-2155-1","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T01:08:46Z","timestamp":1483664926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Risk factors and characteristics of blood stream infections in patients with newly diagnosed multiple myeloma"],"prefix":"10.1186","volume":"17","author":[{"given":"Chun-Teng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Shen","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Tsung","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Tsai","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyh-Pyng","family":"Gau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hwai","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzeon-Jye","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hwang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muh-Hwa","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Ju","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,6]]},"reference":[{"key":"2155_CR1","first-page":"517","volume":"79","author":"HC Rayner","year":"1991","unstructured":"Rayner HC, Haynes AP, Thompson JR, Russell N, Fletcher J. Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988. Q J Med. 1991;79:517\u201325.","journal-title":"Q J Med"},{"key":"2155_CR2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s002770100330","volume":"80","author":"H Murakami","year":"2001","unstructured":"Murakami H, Hayashi K, Hatsumi N, Saitoh T, Yokohama A, Matsushima T, et al. Risk factors for early death in patients undergoing treatment for multiple myeloma. Ann Hematol. 2001;80:452\u20135.","journal-title":"Ann Hematol"},{"key":"2155_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78:21\u201333.","journal-title":"Mayo Clin Proc"},{"key":"2155_CR4","doi-asserted-by":"crossref","first-page":"9219","DOI":"10.1200\/JCO.2005.03.2086","volume":"23","author":"BM Augustson","year":"2005","unstructured":"Augustson BM, Begum G, Dunn JA, Barth NJ, Davies F, Morgan G, et al. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002\u2014Medical Research Council Adult Leukaemia Working Party. J Clin Oncol. 2005;23:9219\u201326.","journal-title":"J Clin Oncol"},{"key":"2155_CR5","first-page":"282","volume":"13","author":"DR Jacobson","year":"1986","unstructured":"Jacobson DR, Zolla-Pazner S. Immunosuppression and infection in multiple myeloma. Semin Oncol. 1986;13:282\u201390.","journal-title":"Semin Oncol"},{"key":"2155_CR6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.beha.2005.01.013","volume":"18","author":"J Blade","year":"2005","unstructured":"Blade J, Rosinol L. Renal, hematologic and infectious complications in multiple myeloma. Best Pract Res Clin Haematol. 2005;18:635\u201352.","journal-title":"Best Pract Res Clin Haematol"},{"key":"2155_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-96-1-47","volume":"96","author":"DG Savage","year":"1982","unstructured":"Savage DG, Lindenbaum J, Garrett TJ. Biphasic pattern of bacterial infection in multiple myeloma. Ann Intern Med. 1982;96:47\u201350.","journal-title":"Ann Intern Med"},{"key":"2155_CR8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1751-553X.2009.01154.x","volume":"31","author":"GN Kalambokis","year":"2009","unstructured":"Kalambokis GN, Christou L, Tsianos EV. Multiple myeloma presenting with an acute bacterial infection. Int J Lab Hematol. 2009;31:375\u201383.","journal-title":"Int J Lab Hematol"},{"key":"2155_CR9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working G","year":"2003","unstructured":"International Myeloma Working G. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749\u201357.","journal-title":"Br J Haematol"},{"key":"2155_CR10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309\u201332.","journal-title":"Am J Infect Control"},{"key":"2155_CR11","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blade J, et al. International staging system for multiple myeloma. J Clin Oncol. 2005;23:3412\u201320.","journal-title":"J Clin Oncol"},{"key":"2155_CR12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.blre.2008.10.003","volume":"23","author":"LJ Worth","year":"2009","unstructured":"Worth LJ, Slavin MA. Bloodstream infections in haematology: risks and new challenges for prevention. Blood Rev. 2009;23:113\u201322.","journal-title":"Blood Rev"},{"key":"2155_CR13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2141.2004.04891.x","volume":"125","author":"DH Kim","year":"2004","unstructured":"Kim DH, Kim JG, Sohn SK, Sung WJ, Suh JS, Lee KS, et al. Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation. Br J Haematol. 2004;125:217\u201324.","journal-title":"Br J Haematol"},{"key":"2155_CR14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/cncr.23168","volume":"112","author":"G Angulo De","year":"2008","unstructured":"De Angulo G, Yuen C, Palla SL, Anderson PM, Zweidler-McKay PA. Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies. Cancer. 2008;112:407\u201315.","journal-title":"Cancer"},{"key":"2155_CR15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3109\/10428194.2013.813504","volume":"55","author":"C Jeune Le","year":"2014","unstructured":"Le Jeune C, Bertoli S, Elhamri M, Vergez F, Borel C, Huguet F, et al. Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemia. Leuk Lymphoma. 2014;55:855\u201362.","journal-title":"Leuk Lymphoma"},{"key":"2155_CR16","doi-asserted-by":"crossref","unstructured":"Jimenez-Zepeda VH, Reece DE, Trudel S, Chen C, Franke N, Winter A, et al. Absolute lymphocyte count as predictor of overall survival for patients with multiple myeloma treated with single autologous stem cell transplant. Leuk Lymphoma. 2015;56(9):2668\u201373.","DOI":"10.3109\/10428194.2014.1003057"},{"key":"2155_CR17","doi-asserted-by":"crossref","first-page":"R192","DOI":"10.1186\/cc9309","volume":"14","author":"CP Jager de","year":"2010","unstructured":"de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever PC. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010;14:R192.","journal-title":"Crit Care"},{"key":"2155_CR18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000085623","volume":"51","author":"FD Wang","year":"2005","unstructured":"Wang FD, Lin ML, Liu CY. Bacteremia in patients with hematological malignancies. Chemotherapy. 2005;51:147\u201353.","journal-title":"Chemotherapy"},{"key":"2155_CR19","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.leukres.2013.06.008","volume":"37","author":"D Tan","year":"2013","unstructured":"Tan D, Kim K, Kim JS, Eom HS, Teoh G, Ong KH, et al. The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): a joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma network. Leuk Res. 2013;37:1070\u20136.","journal-title":"Leuk Res"},{"key":"2155_CR20","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","volume":"28","author":"SK Kumar","year":"2014","unstructured":"Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28:1122\u20138.","journal-title":"Leukemia"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-2155-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T12:56:08Z","timestamp":1589720168000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-2155-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,6]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2155"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-2155-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,6]]},"article-number":"33"}}